Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: Implications for oral prophylaxis of vitamin K deficiency bleeding

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 2, 2003, Pages

  Pereira, S P ^a   Shearer, M J ^b   Williams, R ^c   Mieli Vergani, G ^d  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHYTOMENADIONE; PROTHROMBIN;

ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; HYPERBILIRUBINEMIA; INFANT; INTESTINE ABSORPTION; MALABSORPTION; MALE; NEWBORN; NEWBORN HEMORRHAGIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; TREATMENT OUTCOME; VITAMIN K DEFICIENCY;

EID: 0037373612     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.88.2.f113     Document Type: Article

References (61)

1. Hathaway WE. New insights on vitamin K. Hematol Oncol Clin North Am 1987;1:367-79.
2. Shearer MJ. Vitamin K. Lancet 1995;345:229-34.
3. Sutor AH, von Kries R, Cornelissen EA, et al. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 1999;81:456-61.
4. Bhanchet P, Tuchinda S, Hathirat P, et al. A bleeding syndrome in infants due to acquired prothrombin complex deficiency: a survey of 93 affected infants. Clin Pediatr 1977;16:992-8.
5. Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr 1985;106:351-9.
6. Hanawa Y, Maki M, Murata B, et al. The second nation-wide survey in Japan of vitamin K deficiency in infancy. Eur J Pediatr 1988;147:472-7.
7. Chuansumrit A, Isarangkura P, Hathirat P, et al. Vitamin K deficiency bleeding in Thailand: a 32-year history. Southeast Asian J Trop Med Pub Health 1998;29:649-54.
8. von Kries R. Oral versus intramuscular phytomenadione: safety and efficacy compared. Drug Safety 1999;21:1-6.
9. McNinch AW, Tripp JH. Haemorrhagic disease of the newborn in the British Isles: two year prospective study. BMJ 1991;303:1105-9.
10. McNinch AW, Barton J, Tripp JH. Vitamin K deficiency bleeding in the British Isles and the changing pattern of vitamin K prophylaxis. In: Sutor AH, Hathaway WE, eds. Vitamin K in infancy. Stuttgart: Schattaeur, 1995:165-72.
11. Ekelund H. Late haemorrhagic disease in Sweden 1987-89. Acta Paediatr Scand 1991;80:966-8.
12. Hansen KN, Ebbesen F. Neonatal vitamin K prophylaxis in Denmark: three years' experience with oral administration during the first three months of life compared with one oral administration at birth. Acta Paediatr 1996;85:1137-9.
13. 1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland. Eur J Pediatr 1999;158:599-602.
14. von Kries R, Hachmeister A, Gobel U. Can 3 oral 2 mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding? Eur J Pediatr 1999;158(suppl 3):S183-6.
15. 1. Lancet 1985;1:1035.
16. Koopman LP, Plotz FB, Meuzelaar JJ, et al. Thymic cyst haemorrhages and transient cholestasis in a 4-week-old infant. Eur J Pediatr 1998;157:236-8.
17. Matsuda I, Motohara K, Endo F, et al. Vitamin K prevention of neonatal and late neonatal bleeding. Acta Paediatr Jpn 1989;31:436-8.
18. von Kries R, Kordass U, Shearer MJ, et al. Idiopathic late hemorrhagic disease of newborn and conjugated hyperbilirubinemia. J Pediatr Gastroenterol Nutr 1993;16:328-30.
19. Loughnan PM, McDougall PN. Epidemiology of late onset haemorrhagic disease: a pooled data analysis. J Paediatr Child Health 1993;29:177-81.
20. 1: results of a worldwide postmarketing surveillance programme. Pharmacoepidemiol Drug Safety 1998;7:173-82.
21. 1 to normal breast-fed newborns. J Pediatr Gastroenterol Nutr 1997;24:280-4.
22. 1(20) in children with cholestasis. J Pediatr Gastroenterol Nutr 1992;14:160-5.
23. Barton JS, Tripp JH, McNinch AW. Neonatal vitamin K prophylaxis in the British Isles: current practice and trends. BMJ 1995;310:632-3.
24. von Kries R, Hachmeister A, Gobel U. Repeated oral vitamin K prophylaxis in West Germany: acceptance and efficacy. BMJ 1995;310:1097-8.
25. American Academy of Pediatrics Vitamin K Ad Hoc Task Force. Controversies concerning vitamin K and the newborn. Pediatrics 1993;91:1001-3.
26. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996;16:403-14.
27. Suttie JW. Vitamin K and human nutrition. J Am Diet Assoc 1992;92:585-90.
28. Belle M, Leclercq M, Vignal B, et al. Application of an ELISA test to vitamin K-deficient conditions using a new monoclonal antibody against human des-gamma-carboxy-prothrombins (DCP). In: Sutor AH, Hathaway WE, eds. Vitamin K in infancy. Stuttgart: Schattauer, 1995:123-37.
29. McCarthy PT, Harrington DJ, Shearer MJ. Assay of phylloquinone in plasma by HPLC with electrochemical detection. In: McCormick DB, Suttie JW, Wagner C, eds. Methods in Enzymology New York: Academic Press, 1997:421-35.
30. 1) in serum or plasma by HPLC. In: Fidanza F, ed. Nutritional status assessment: a manual for population studies. London: Chapman & Hall, 1991:214-20.
31. Belle M, Brebant R, Guinet R, Leclercq M. Production of a new monoclonal antibody specific to human des-gamma-carboxyprothrombin in the presence of calcium ions. Application to the development of a sensitive ELISA-test. J Immunoassay 1995;16:213-29.
32. Humpl T, Bruhl K, Brzezinska R, et al. Fatal late vitamin K-deficiency bleeding after oral vitamin K prophylaxis secondary to unrecognized bile duct paucity. J Pediatr Gastroenterol Nutr 1999;29:594-7.
33. Motohara K, Endo F, Matsuda I. Vitamin K deficiency in breast-fed infants at one month of age. J Pediatr Gastroenterol Nutr 1986;5:931-3.
34. Greer FR, Marshall SP, Severson RR, et al. A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants. Arch Dis Child 1998;79:300-5.
35. Greer FR, Marshall S, Cherry J, et al. Vitamin K status of lactating mothers, human milk, and breast-feeding infants. Pediatrics 1991;88:751-6.
36. 1 in man. Br J Haematol 1972;22:579-88.
37. 1 after intravenous and oral administration to subjects on phenprocoumon therapy. Int J Pharmacol 1988;48:223-30.
38. 1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newborn. Eur J Clin Pharmacol 1996;49:421-3.
39. Harvey JM, Bell F, Smith C, et al. Subclinical vitamin K deficiency in breast-fed babies aged 8-9 weeks determined by a sensitive EIA for undercarboxylated prothrombin (PIVKA-II) [abstract]. Blood Coag Fibrinol 1998;9:19.
40. 1 and PIVKA-II in bottle-fed and breast-fed infants with and without vitamin K prophylaxis at birth. Eur J Pediatr 1988;148:139-42.
41. Greer FR, Marshall SP, Foley AL, et al. Improving the vitamin K status of breastfeeding infants with maternal vitamin K supplements. Pediatrics 1997;99:88-92.
42. Liebman HA, Furie BC, Tong MJ, et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427-31.
43. Tanaka Y, Kashiwagi T, Tsutsumi H, et al. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma. Hepatogastroenterology 1999;46:2464-8.
44. Okuda H, Nakanishi T, Takatsu K, et al. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity. Cancer 1999;85:812-18.
45. Ohhira M, Ohtake T, Saito H, et al. Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma. Alcohol Clin Exp Res 1999;23:67S-70S.
46. Shapiro AD, Jacobson LJ, Armon ME, et al. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J Pediatr 1986;109:675-80.
47. 1) in man. Vitam Horm 1974;32:513-42.
48. Gijsbers BL, Jie KS, Vermeer C. Effect of food composition on vitamin K absorption in human volunteers. Br J Nutr 1996;76:223-9.
49. McNinch AW, Upton C, Samuels M, et al. Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child 1985;60:814-18.
50. Forsgren L. Studies on the intestinal absorption of labelled fat-soluble vitamins (A, D, E, and K) via the thoracic-duct lymph in the absence of bile in man. Acta Chir Scand Suppl 1969;399:1-29.
51. Golding J, Greenwood R, Birmingham K, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992;305:341-6.
52. IARC monographs on the evaluation of carcinogenic risks to humans. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. Lyon: IARC Press, 2000.
53. Cornelissen M, von Kries R, Loughnan P, et al. Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr 1997;156:126-30.
54. Zipursky A. Prevention of vitamin K deficiency bleeding in newborns. Br J Haematol 1999;104:430-7.
55. von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of scientific and standardization subcommittee on perinatal haemostasis. Thromb Haemost 1993;69:293-5.
56. von Kries R, Hachmeister A, Göbel U. Oral mixed micellar vitamin K for prevention of late vitamin K deficiency bleeding. Arch Dis Child Fetal Neonatal Ed 2003;88:000-000.
57. Wariyar U, Hilton S, Pagan J, et al. Six years' experience of prophylactic oral vitamin K. Arch Dis Child Fetal Neonatal Ed 2000;82:F64-8.
58. Huysman MW, Sauer PJ. The vitamin K controversy. Curr Opin Pediatr 1994;6:129-34.
59. Shearer MJ, Bach A, Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr 1996;126:1181s-6s.
60. Loughnan PM, McDougall PN. Does intramuscular vitamin K1 act as an unintended depot preparation? J Paediatr Child Health 1996;32:251-4.
61. Hagstrom JN, Bovill EG, Soll RF, et al. The pharmacokinetics and lipoprotein fraction distribution of intramuscular vs. oral vitamin K1 supplementation in women of childbearing age: effects on hemostasis. Thromb Haemost 1995;74:1486-90.